Los Angeles Capital Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,339
Closed -$571K 2618
2025
Q4
$571K Buy
89,339
+61,980
+227% +$425K ﹤0.01% 842
2025
Q3
$186K Sell
27,359
-4,217
-13% -$28.5K ﹤0.01% 1278
2025
Q2
$218K Buy
31,576
+4,645
+17% +$31.5K ﹤0.01% 1168
2025
Q1
$196K Buy
+26,931
New +$211K ﹤0.01% 1020
2022
Q3
Sell
-129,852
Closed -$699K 1394
2022
Q2
$699K Sell
129,852
-76,111
-37% -$410K ﹤0.01% 842
2022
Q1
$1.03M Hold
205,963
﹤0.01% 747
2021
Q4
$1.07M Sell
205,963
-393
-0.2% -$2.19K ﹤0.01% 705
2021
Q3
$1.15M Sell
206,356
-18,210
-8% -$118K 0.01% 714
2021
Q2
$1.61M Sell
224,566
-15,480
-6% -$134K 0.01% 649
2021
Q1
$2.43M Sell
240,046
-7,903
-3% -$74.4K 0.01% 567
2020
Q4
$1.92M Buy
+247,949
New +$2.18M 0.01% 673

Other funds holding VMD

Los Angeles Capital Management's VMD Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 89,339 shares — an estimated $571K sold.

Los Angeles Capital Management first reported a position in VMD in Q4 2020 and held it in 11 quarters. The position peaked at $2.43M in Q1 2021. 150 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 89,339 Viemed Healthcare shares in Q1 2026, an estimated $571K.
  • Los Angeles Capital Management first reported a position in Viemed Healthcare in Q4 2020 and held it in 11 quarters.
  • Los Angeles Capital Management's Viemed Healthcare position peaked at $2.43M in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.